Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
6 drugs for “CLL”
Approved 3
- SonrotoclaxBeOne Medicines Ltd.CLL
- VenetoclaxAbbVie Inc.Chronic Lymphocytic Leukemia (CLL)
- ZanubrutinibBeOne Medicines Ltd.CLL
Phase 3 3
- LisaftoclaxASCENTAGE PHARMA GROUP INTERNATIONALCLL/SLL
- NemtabrutinibMerck & Co., Inc.CLL
- TacabrutidegBeOne Medicines Ltd.CLL
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.